| Sep 12 |
iRhythm’s Zio ECG monitoring system secures Japanese regulatory approval
|
| Sep 11 |
iRhythm Technologies Announces Japanese Regulatory Approval of the Zio® ECG Monitoring System, the First Product to Deliver Arrhythmia Monitoring Service Utilizing Artificial Intelligence
|
| Sep 10 |
iRhythm Stock Gains Following Favorable Zio Monitor Study Data
|
| Sep 9 |
iRhythm Stock May Gain on Its Latest Deal With BioIntelliSense
|
| Sep 9 |
iRhythm Unveils Data Demonstrating Superior Real-World Performance of Next-Generation Zio® Monitor at HRX 2024 Meeting
|
| Sep 4 |
iRhythm Technologies Enters License Agreement with BioIntelliSense for Multiparameter Sensor Technology to be Used in Ambulatory Cardiac Monitoring
|
| Sep 4 |
iRhythm’s Wearable Monitor Found Heart Arrhythmias. It Didn’t Stop Strokes.
|
| Sep 1 |
iRhythm Technologies Announces Results of GUARD-AF Trial
|
| Aug 30 |
iRhythm Technologies Launches Zio Monitoring Across Europe
|
| Aug 29 |
iRhythm Technologies Expands Global Reach with the Launch of Zio® Cardiac Arrhythmia Monitoring Service in Austria, the Netherlands, Switzerland, and Spain
|
